nodes	percent_of_prediction	percent_of_DWPC	metapath
Melphalan—ovarian cancer—polycystic ovary syndrome	0.703	1	CtDrD
Melphalan—SLC22A3—Metformin—polycystic ovary syndrome	0.272	1	CbGbCtD
Melphalan—SLC7A5—endometrium—polycystic ovary syndrome	0.00175	0.094	CbGeAlD
Melphalan—SLC7A5—uterus—polycystic ovary syndrome	0.00162	0.0866	CbGeAlD
Melphalan—SLC7A5—pituitary gland—polycystic ovary syndrome	0.00159	0.0851	CbGeAlD
Melphalan—SLC7A5—adipose tissue—polycystic ovary syndrome	0.00158	0.0847	CbGeAlD
Melphalan—SLC22A3—embryo—polycystic ovary syndrome	0.00149	0.0797	CbGeAlD
Melphalan—SLC7A5—adrenal gland—polycystic ovary syndrome	0.00142	0.076	CbGeAlD
Melphalan—SLC7A5—female gonad—polycystic ovary syndrome	0.00132	0.0709	CbGeAlD
Melphalan—SLC7A5—vagina—polycystic ovary syndrome	0.00131	0.0704	CbGeAlD
Melphalan—SLC7A5—endocrine gland—polycystic ovary syndrome	0.00123	0.0659	CbGeAlD
Melphalan—L-Tyrosine—TH—polycystic ovary syndrome	0.00122	0.353	CrCbGaD
Melphalan—SLC22A3—endometrium—polycystic ovary syndrome	0.00109	0.0583	CbGeAlD
Melphalan—SLC22A3—adipose tissue—polycystic ovary syndrome	0.000981	0.0526	CbGeAlD
Melphalan—SLC22A3—adrenal gland—polycystic ovary syndrome	0.00088	0.0472	CbGeAlD
Melphalan—SLC22A3—female gonad—polycystic ovary syndrome	0.00082	0.044	CbGeAlD
Melphalan—SLC22A3—vagina—polycystic ovary syndrome	0.000815	0.0437	CbGeAlD
Melphalan—Ibuprofen—PLAT—polycystic ovary syndrome	0.00081	0.234	CrCbGaD
Melphalan—SLC22A3—endocrine gland—polycystic ovary syndrome	0.000763	0.0409	CbGeAlD
Melphalan—L-Phenylalanine—TH—polycystic ovary syndrome	0.000708	0.205	CrCbGaD
Melphalan—Ibuprofen—BCL2—polycystic ovary syndrome	0.000465	0.134	CrCbGaD
Melphalan—Respiratory distress—Metformin—polycystic ovary syndrome	0.000343	0.108	CcSEcCtD
Melphalan—Ibuprofen—PPARG—polycystic ovary syndrome	0.000258	0.0745	CrCbGaD
Melphalan—Neuropathy—Metformin—polycystic ovary syndrome	0.000204	0.0646	CcSEcCtD
Melphalan—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.000146	0.0461	CcSEcCtD
Melphalan—Neutropenia—Metformin—polycystic ovary syndrome	0.000128	0.0404	CcSEcCtD
Melphalan—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.000119	0.0377	CcSEcCtD
Melphalan—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.000115	0.0364	CcSEcCtD
Melphalan—Hepatitis—Metformin—polycystic ovary syndrome	0.000109	0.0345	CcSEcCtD
Melphalan—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.000107	0.0339	CcSEcCtD
Melphalan—Flushing—Metformin—polycystic ovary syndrome	0.000101	0.0321	CcSEcCtD
Melphalan—Immune system disorder—Metformin—polycystic ovary syndrome	9.87e-05	0.0312	CcSEcCtD
Melphalan—Mediastinal disorder—Metformin—polycystic ovary syndrome	9.85e-05	0.0311	CcSEcCtD
Melphalan—Myalgia—Metformin—polycystic ovary syndrome	8.1e-05	0.0256	CcSEcCtD
Melphalan—Chest pain—Metformin—polycystic ovary syndrome	8.1e-05	0.0256	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	8.05e-05	0.0254	CcSEcCtD
Melphalan—Oedema—Metformin—polycystic ovary syndrome	7.77e-05	0.0245	CcSEcCtD
Melphalan—Infection—Metformin—polycystic ovary syndrome	7.72e-05	0.0244	CcSEcCtD
Melphalan—Thrombocytopenia—Metformin—polycystic ovary syndrome	7.6e-05	0.024	CcSEcCtD
Melphalan—Skin disorder—Metformin—polycystic ovary syndrome	7.54e-05	0.0238	CcSEcCtD
Melphalan—Anorexia—Metformin—polycystic ovary syndrome	7.4e-05	0.0234	CcSEcCtD
Melphalan—Hypotension—Metformin—polycystic ovary syndrome	7.26e-05	0.0229	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	7.08e-05	0.0224	CcSEcCtD
Melphalan—Paraesthesia—Metformin—polycystic ovary syndrome	6.97e-05	0.022	CcSEcCtD
Melphalan—Dyspnoea—Metformin—polycystic ovary syndrome	6.92e-05	0.0219	CcSEcCtD
Melphalan—Dyspepsia—Metformin—polycystic ovary syndrome	6.84e-05	0.0216	CcSEcCtD
Melphalan—Decreased appetite—Metformin—polycystic ovary syndrome	6.75e-05	0.0213	CcSEcCtD
Melphalan—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	6.7e-05	0.0212	CcSEcCtD
Melphalan—Fatigue—Metformin—polycystic ovary syndrome	6.7e-05	0.0212	CcSEcCtD
Melphalan—Urticaria—Metformin—polycystic ovary syndrome	6.17e-05	0.0195	CcSEcCtD
Melphalan—Asthenia—Metformin—polycystic ovary syndrome	5.57e-05	0.0176	CcSEcCtD
Melphalan—Pruritus—Metformin—polycystic ovary syndrome	5.49e-05	0.0174	CcSEcCtD
Melphalan—Diarrhoea—Metformin—polycystic ovary syndrome	5.31e-05	0.0168	CcSEcCtD
Melphalan—Vomiting—Metformin—polycystic ovary syndrome	4.94e-05	0.0156	CcSEcCtD
Melphalan—Rash—Metformin—polycystic ovary syndrome	4.9e-05	0.0155	CcSEcCtD
Melphalan—Dermatitis—Metformin—polycystic ovary syndrome	4.89e-05	0.0155	CcSEcCtD
Melphalan—Nausea—Metformin—polycystic ovary syndrome	4.61e-05	0.0146	CcSEcCtD
